Suboptimal peak inspiratory flow rate in COPD patients: the importance of assessment in clinical practice. Expert Council Consensus

Pharmacotherapy for patients with chronic obstructive pulmonary disease is administered through various inhalation devices. The inhalers have different designs, principles of operation and activation methods, the number of steps necessary to prepare the device for use, the resistance that the patient has to overcome with inhalation, and many other characteristics. The suboptimal choice of an inhalation device may affect the clinical outcomes of the disease. Therefore, the guidelines consider replacement of the inhaler to be an alternative to escalation of therapy with treatment failure. When choosing an inhalation device, a number of the patient’s clinical features should be considered, including the patient's ability to induce an inspiration effort. Since devices that estimate the force of inspiratory effort at different resistances are not available in Russian Federation for routine clinical practice, the expert group described some clinical features that may be observed in patients with suboptimal inspiratory flow based on the existing data. Their final choice was made by voting according to the Delphi panel method that accounts for the opinion of each expert.

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2020 Report. Available at: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMVpdf [Accessed: July 03, 2020].

2. Mahler D.A. The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease. Respir. Med. 2020; 161: 105857. DOI: 10.1016/j.rmed.2019.105857.

3. Iwanaga T., Kozuka T., Nakanishi J. et al. Aerosol deposition of inhaled corticosteroids/long-acting e2-agonists in the peripheral airways of patients with asthma using functional respiratory imaging, a novel imaging technology. Pulm. Ther. 2017; 3: 219-231. DOI: 10.1007/s41030-017-0036-4.

4. Harb H.S., Laz N.I., Rabea H., Abdelrahim M.E.A. Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients. Eur. J. Pharm. Sci. 2020; 147: 105298. DOI: 10.1016/j.ejps.2020.105298.

5. Azouz W., Chrystyn H. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. Prim. Care Respir. J. 2012; 21 (2): 208-213. DOI: 10.4104/pcrj.2012.00010.

6. Ghosh S., Ohar J.A., Drummond M.B. Peak Inspiratory flow rate in chronic obstructive pulmonary disease: Implications for dry powder inhalers. J. Aerosol. Med. Pulm. Drug Deliv. 2017; 30 (6): 381-387. DOI: 10.1089/jamp.2017.1416.

7. Sanders M.J. Guiding inspiratory flow: Development of the in-check DIAL G16, a tool for improving inhaler technique. Pulm. Med. 2017; 2017: 1495867. DOI: 10.1155/2017/1495867.

8. Loh C.H., Peters S.P., Lovings T.M., Ohar J.A. Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissions. Ann. Am. Thorac. Soc. 2017; 14 (8): 1305-1311. DOI: 10.1513/AnnalsATS.201611-903OC.

9. Sharma G., Mahler D.A., Mayorga V.M. et al. Prevalence of Low Peak Inspiratory Flow Rate at Discharge in Patients Hospitalized for COPD Exacerbation. Chronic Obstr. Pulm. Dis. 2017; 4 (3): 217-224. DOI: 10.15326/jcopdf.4.3.2017.0183.

10. Malmberg L.P., Rytila P., Happonen P., Haahtela T. Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters. Int. J. Chron. Obstruct. Pulmon. Dis. 2010; 5: 257-262. DOI: 10.2147/copd.s11474.

11. Mahler D.A., Waterman L.A., Gifford A.H. Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler. J. Aerosol. Med. Pulm. Drug Deliv. 2013; 26 (3): 174-179. DOI: 10.1089/jamp.2012.0987.

12. Janssens W., VandenBrande P., Hardeman E. et al. Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur. Respir. J. 2008; 31 (1): 78-83. DOI: 10.1183/09031936.00024807.

13. Seheult J.N., Costello S., Tee K.C. et al. Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study. SpringerPlus. 2014; 3: 496. DOI: 10.1186/2193-1801-3-496.

14. Duarte A.G., Tung L., Zhang W et al. Spirometry measurement of peak inspiratory flow identifies suboptimal use of dry powder inhalers in ambulatory patients with COPD. Chronic. Obstr. Pulm. Dis. 2019; 6 (3): 246-255. DOI: 10.15326/jcopdf.6.3.2018.0163.

15. Watz H., Tetzlaff K., Magnussen H. et al. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial. Respir. Res. 2018; 19 (1): 251. DOI: 10.1186/s12931-018-0944-3.

16. O'Donnell D.E., Elbehairy A.F., Webb K.A., Neder J.A. The link between reduced inspiratory capacity and exercise intolerance in chronic obstructive pulmonary disease. Ann. Am. Thorac. Soc. 2017; 14 (Suppl. 1): S30-39. DOI: 10.1513/AnnalsATS.201610-834FR.

17. Samarghandi A., Ioachimescu O.C., Qayyum R. Association between peak inspiratory flow rate and hand grip muscle strength in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. PLoS One. 2020; 15 (1): e0227737. DOI: 10.1371/journal.pone.0227737.

18. Jarvis S., Ind P.W., Shiner R.J. Inhaled therapy in elderly COPD patients; time for re-evaluation? Age Ageing. 2007; 36 (2): 213-218. DOI: 10.1093/ageing/afl174.

19. Ghosh S., Pleasants R.A., Ohar J.A. et al. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2019; 14: 585-595. DOI: 10.2147/COPD.S195438.

20. Miravitlles M., Alcdzar B., Alvarez F. et al. What pulmonologists think about the asthma-COPD overlap syndrome. Int. J. Chron. Obstruct. Pulmon. Dis. 2015; 10 (1): 1321-1330. DOI: 10.2147/COPD.S88667.